PrimaryMarkets

VIEW OUR WEBINARS

SOFI Spritz - Australia’s Aperitivo
SOFI Spritz - Australia’s Aperitivo
View Recording

Deal Snapshot
Deal Snapshot
View Recording

Pre-IPO Trading with PrimaryMarkets
Pre-IPO Trading with PrimaryMarkets
View Recording

AIRR - Profile Video
AIRR - Profile Video
View Recording

Deal Snapshot
Deal Snapshot
View Recording

Biopharmaceutical Company founded by Australian Nobel Laureate - Patented Product for Treatments of Allergy Indications

Categories Securities, Unissued Securities
Sale Type Price on Application
Price Guide AUD A$3.5M raise at A$0.05 per share - A$2.75M already raised (pre-money valuation of A$1.57M)
Status: Closed

Summary:

Unlisted Australian company founded by Australian Nobel Laureate to develop and commercialise novel treatments in rapidly growing international market for allergic indications including childhood eczema, food allergies, allergic asthma. Funds required to complete pre-clinical studies and quality manufacture of patented product for use in animal safety studies and clinical trials.

 

 

Share this Listing

 

Go Back

Become a Follower